SMTL ID : 6ubw.1

MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 84S: N-(6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}imidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide(Non-covalent)

84S.1: 18 residues within 4Å: Chain A: I.67, V.75, A.91, L.123, L.140, P.141, Y.142, M.143, K.144, G.146, D.147, R.191, N.192, M.194, A.204, D.205, A.209, Y.213 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.91, A:A.204, A:D.205, A:Y.213 Hydrogen bonds: A:M.143, A:M.143, A:D.147, A:D.205, A:Y.213 Water bridges: A:D.147 pi-Stacking: A:Y.213

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 7 residues within 4Å: Chain A: T.160, V.161, K.162, F.327, G.329, E.330, H.331 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farrell, P.J. et al., MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody. Mol.Cancer Ther. (2017)

Release Date

2020-02-12

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence